V Hasselblad Selected Research

V Hasselblad Research Topics

3	Heart Failure 07/2011 - 04/2001
3	Infarction (Infarctions) 11/2001 - 03/2001
2	Hemorrhage 02/2004 - 11/2001
2	Thrombosis (Thrombus) 11/2001 - 03/2001
2	Acute Coronary Syndrome 06/2001 - 03/2001
1	Dyspnea (Shortness of Breath) 07/2011
1	Hypertension (High Blood Pressure) 09/2008
1	ST Elevation Myocardial Infarction 01/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2003
1	Anemia 08/2001
1	Neoplasms (Cancer) 08/2001
1	Second Primary Neoplasms (Neoplasms, Second) 08/2001
1	Ischemia 06/2001
1	Mitral Valve Insufficiency (Mitral Regurgitation) 04/2001
1	Prostatic Neoplasms (Prostate Cancer) 04/2000
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 02/2000
1	Glaucoma 02/2000
1	Cataract (Cataracts) 02/2000
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2000

1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2008
1	Angiotensin IIIBA 09/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2008
1	BradykininIBA 09/2008
1	SaltsIBA 09/2008
1	(2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acidIBA 02/2004
1	Enoxaparin (Lovenox)FDA LinkGeneric 11/2001
1	Hemoglobins (Hemoglobin)IBA 08/2001
1	paragonIBA 06/2001
1	Glycoproteins (Glycoprotein)IBA 06/2001
1	Trinitrotoluene (TNT)IBA 06/2001
1	Troponin T (Troponin T1)IBA 06/2001
1	Natriuretic PeptidesIBA 04/2001
1	Thrombin FDA Link 03/2001
1	Heparin (Liquaemin)FDA LinkGeneric 03/2001
1	AntithrombinsIBA 03/2001
1	HirudinsIBA 03/2001
1	Pharmaceutical PreparationsIBA 03/2001
1	AndrogensIBA 04/2000
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2000

5	Therapeutics 07/2011 - 04/2000
1	Patient Readmission 07/2011
1	Length of Stay 01/2003
1	Stents 11/2001
1	Erythrocyte Transfusion 08/2001
1	Catheters 04/2001
1	Aftercare (After-Treatment) 03/2001
1	Intraocular Lenses (Intraocular Lens) 02/2000
1	Intraocular Lens Implantation 02/2000